Universiteit Antwerpen
OrganisationROR
People
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Sources: openalex.org
Trials
Phase 3, Recruiting, 240 people, 9 Dec 2022
Phase 3, Status unknown, 290 people, 5 Feb 2019
Collaborator, Phase 2, Terminated, 39 people, 11 Jan 2010
Collaborator, Phase 3, Completed, 104 people, 13 Oct 2008
Collaborator, Phase 2, Completed, 77 people, 20 Apr 2007
Grants and prizes
BOF - doctoral mandates, Cardiovascular effects of endurance exercise in female master athletes: mechanisms of coronary plaque formation and cardiac remodeling, vlaamse-69ffb049-c42c-482f-af32-da53d3b1f83c, 2026–2030, 1 Jul 2026
BOF - doctoral mandates, The role of sex on the effects of ERBB4 agonists as a treatment for heart failure, 56484, 2026–2030, 1 Jul 2026
BOF - doctoral mandates, The role of sex on the effects of ERBB4 agonists as a treatment for heart failure, 57255, 2026–2030, 1 Jul 2026
BOF - projects, Recurrent Chromosomal Junctions as Universal Biomarkers for Non-Invasive Detection of Pleural Mesothelioma., vlaamse-4615b4d0-4b10-48d2-9d4d-b197824952cf, 2026–2027, 1 Apr 2026
Fonds Wetenschappelijk Onderzoek
FWO research project (including WEAVE projects), Bridging the Research gap between sleep Apnea syndrome, Vascular and cardiac Outcomes (BRAVO)., G015326N, 2026–2029, 1 Apr 2026
HORIZON-TMA-MSCA-PF-EF, A Dual Amplification Photoelectrochemical Platform for KRAS Mutation Detection, 101280504, €216.2k, 2027–2029, 31 Mar 2026
IOF - technology validation in lab, ESCAPE: developing a scalable, cost-effective multi-cancer early detection test using IMPRESS technology., vlaamse-4e229876-e313-4402-9f61-d97a4fb85e24, 2026, 1 Jan 2026
HORIZON-JU-RIA, Cities@Heart: City-based Strategies for improving Cardiovascular Health in Europe, 101219389, €706.4k, 2026–2030, 17 Dec 2025
BOF - doctoral mandates, Event-related potentials during auditory and visual oddball as an objective biomarker for cognitive functioning independent of hearing., vlaamse-69a103be-e5dd-4029-8621-cbc29102e022, 2025–2028, 1 Nov 2025
BOF - doctoral mandates, Using big data to strengthen the evidence about effects of prescribing and deprescribing of medications in older people with limited life-expectancy., vlaamse-5ca8406f-09dc-422a-8eed-98ff45cba491, 2025–2026, 15 Jul 2025
Fonds Wetenschappelijk Onderzoek
FWO research project (including WEAVE projects), ELLA: Exploring Lactobacilli for Localized Applications., G0ATZ25N, 2025–2029, 1 Jul 2025
BOF - projects, From Tear Drops to Diagnostics: Profiling Tear RNA for Early Biomarker Discovery in Alzheimer's Disease., vlaamse-13fa77c4-ef9c-43f6-a7a2-9c7e1ed4e454, 2025–2026, 1 Apr 2025
HORIZON-ERC-POC, The initial stream of a urine void., 101212832, €150k, 2025–2026, 26 Feb 2025
Fonds Wetenschappelijk Onderzoek
FWO Applied Biomedical Research (TBM), Targeting muscle strength loss due to hospitalization in older adults by blood-flow restriction combined with an EMG driven serious game (GHOSTLY)., T000425N, 2025–2028, 1 Jan 2025
BOF - doctoral mandates, Event-related potentials during auditory and visual oddball as an objective biomarker for cognitive functioning independent of hearing., vlaamse-ae776249-ea18-4102-8391-9a8b6c452a05, 2024–2025, 1 Nov 2024
BOF - ZAP BOF mandates, Integrated Care: changing landscape, new needs., vlaamse-5874f44c-8d9f-49f8-9331-1401579b3717, 2024–2029, 1 Oct 2024
BOF - doctoral mandates, Investigating SERPINA3 as target and predictive marker in chemotherapy-induced cardiovascular dysfunction., vlaamse-6ea480b0-e425-4bff-860c-11af702e2aa6, 2024–2028, 1 Oct 2024
BOF - doctoral mandates, ECHOES: Unraveling the interplay between hearing loss, cognitive decline and tauopathy: The role of neuroinflammation and neurodegeneration in the hippocampus., vlaamse-64a574ba-52ed-4389-b503-878d3fb5015c, 2024–2028, 1 Oct 2024
HORIZON-TMA-MSCA-DN, Exploring the therapeutic potential of perinatal cell SECRETomes, 101168752, €525.2k, 2024–2028, 16 Jul 2024
HORIZON-RIA, City based interventions to stimulate active movement for health, 101136358, €892.6k, 2024–2027, Lead, 1 Dec 2023
Sources: openalex.org, cordis.europa.eu
Funded papers
Ageing processes in the bonobo gut microbiome mirror human patterns
DOCPRO37054, 3 Sept 2026
Sources: api.crossref.org